Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002133 · ClinicalTrials.gov registry record · NA
An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.
A NA study, sponsored by Janssen.
- Completed
- Registry status
- NA
- Development phase
NCT00002133 is a NA study that has completed, run by Janssen.
The verdict
NCT00002133, a NA study, has completed, sponsored by Janssen.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To assess the efficacy and safety of itraconazole oral solution in HIV-seropositive patients with oropharyngeal candidiasis that is refractory to fluconazole.
Interventions
- DRUG Itraconazole
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002133
The ClinicalTrials.gov registry entry for NCT00002133 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Janssen, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Itraconazole is the first listed.
NCT00002133 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002133 about?
NCT00002133 is a clinical study titled "An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.". To assess the efficacy and safety of itraconazole oral solution in HIV-seropositive patients with oropharyngeal candidiasis that is refractory to fluconazole.
What is the current status of trial NCT00002133?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002133?
The interventions under investigation include: Itraconazole (DRUG).
Who is sponsoring clinical trial NCT00002133?
This trial is sponsored by Janssen, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.